ArticleAnnals of gastroenterology

Infliximab biosimilar CT-P13 is effective and safe in treating inflammatory bowel diseases: a real-life multicenter, observational study in Italian primary inflammatory bowel disease centers.

Antonio Tursi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.